Nilesh Shah - Metropolis Healthcare Group Innovation
| METROPOLIS | 1,614 18.65 1.17% |
Executive
Nilesh Shah is Group Innovation of Metropolis Healthcare Limited
| Address | East Wing, Plot-254 B, Nirlon House, Mumbai, India, 400030 |
| Phone | 91 8422 801 801 |
| Web | https://www.metropolisindia.com |
Metropolis Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0863 % which means that it generated a profit of $0.0863 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1329 %, meaning that it generated $0.1329 on every $100 dollars invested by stockholders. Metropolis Healthcare's management efficiency ratios could be used to measure how well Metropolis Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Metropolis Healthcare's Net Tangible Assets are very stable compared to the past year. As of the 25th of March 2025, Non Current Assets Total is likely to grow to about 15 B, while Total Assets are likely to drop about 9.2 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Vineesh Ghei | Healthcare Global Enterprises | 51 | |
| Amrut Medhekar | Akums Drugs and | N/A | |
| Meghraj Gore | Healthcare Global Enterprises | 49 | |
| Jayant Barde | Mangalam Drugs And | 30 | |
| Sumeet Sood | Akums Drugs and | N/A | |
| Nikunjkumar Savaliya | SANOFI S HEALTHC | N/A | |
| Vishal Saxena | ideaForge Technology Limited | N/A | |
| Anuradha Pandey | Mangalam Drugs And | 32 | |
| Shantanu Chobhe | Akums Drugs and | N/A | |
| Mansi Pathak | Mangalam Drugs And | 46 | |
| Sanjay Sharma | Akums Drugs and | N/A | |
| Rakesh Srivastava | Mangalam Drugs And | 51 | |
| Jitendra Mishra | Akums Drugs and | N/A | |
| Pradeep Mehta | Garware Hi Tech Films | N/A | |
| Nilesh Jaywant | ideaForge Technology Limited | N/A | |
| Amol Suryawanshi | ideaForge Technology Limited | N/A | |
| Awaneesh Srivastava | Garware Hi Tech Films | N/A | |
| Ajay Samant | Mangalam Drugs And | N/A | |
| Bhanvesh Naik | Mangalam Drugs And | 46 | |
| Venkataraman | Garware Hi Tech Films | N/A | |
| Manisha Kumar | Healthcare Global Enterprises | 38 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0863 |
Metropolis Healthcare Leadership Team
Elected by the shareholders, the Metropolis Healthcare's board of directors comprises two types of representatives: Metropolis Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Metropolis. The board's role is to monitor Metropolis Healthcare's management team and ensure that shareholders' interests are well served. Metropolis Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Metropolis Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pinakin Shah, Chief Officer | ||
| Neha Shah, Interim Secretary | ||
| Simmi Bisht, Company Secretarial | ||
| Sushil Shah, Founder Chairman | ||
| Ishita Medhekar, Chief Officer | ||
| Bhoopendra Rajawat, North West | ||
| Kirti Chadha, Chief Officer | ||
| Abdur Razzaque, Group Head | ||
| Puneet Nigam, Chief Officer | ||
| Sriram Iyer, Chief Officer | ||
| Nilesh Shah, Group Innovation | ||
| Ameera Shah, Executive Chairperson | ||
| Jeyasingh Balakrishnan, Head Communications | ||
| Kannan Alangadan, Healthtech Operations | ||
| Umesh Rai, Head Business | ||
| Kamlesh Kulkarni, Company Officer | ||
| Ronica Baruah, Chief services | ||
| Pranav Desai, Managing Services | ||
| Sameer Patel, Chief Officer | ||
| Avadhut Joshi, Chief Officer | ||
| Anita Suryanarayan, VP services | ||
| Balakrishnan Janardhanan, Chief India | ||
| Surendran Chemmenkotil, Chief Officer | ||
| Rakesh Agarwal, Chief Officer | ||
| Geeta Chopra, Delhi Ltd | ||
| Aditya Shinde, Interim Officer | ||
| Tarun Gaur, Head Automation | ||
| Manish Rastogi, Head Application | ||
| Ajit Golwilkar, Chief Pune | ||
| Mohan Menon, Chief Officer | ||
| H Ravikumar, Managing Metropolis | ||
| Pradeep Mahindrakar, Chief Mumbai |
Metropolis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Metropolis Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0863 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 82.69 B | ||||
| Shares Outstanding | 51.28 M | ||||
| Shares Owned By Insiders | 49.30 % | ||||
| Shares Owned By Institutions | 45.98 % | ||||
| Price To Book | 6.99 X | ||||
| Price To Sales | 6.28 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Metropolis Stock
Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.